← Evidence map

ArticleCancers2022

TRAIL Receptor Targeting Agents Potentiate PARP Inhibitor Efficacy in Pancreatic Cancer Independently of

Najib Ben Khaled et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36358659